As the number of asthmatics, COPD, and allergy patients continues to grow, the upper respiratory treatment market is attracting a number of new companies – companies with some novel approaches to the problem of chronic airway inflammation. These companies are conducting ongoing........more

Delivering drugs to the central nervous system presents unique challenges. But, drug developers and researchers have discovered that delivering CNS therapeutic drugs via inhalation mitigates several of these issues. The accessibility and vascular structure of the nose make it an attractive route for delivering.........more

Therapeutic cancer vaccines, long deemed one of the most commercially attractive pharmaceutical business opportunities and a highly-cherished health care objective, are beginning to show promise for a number of cancers. A growing list of companies are entering the race to .........more

Drugs based on immune system modulation - a class that includes cytokines, lymphocyte receptors, signaling enzymes, antibodies and transcription factors - have demonstrated the capability to effectively treat a host of diseases that had previously been considered to be intractable.........more

As new-generation cardiac devices and cardiac event monitoring products converge with wireless networks, medical professionals are acquiring the capability to monitor key patient parameters and implanted device data in near-real time. These new communication-enabled devices function like ........more

While their use is still the subject of much clinical testing and professional debate, embolic protection devices are carving a growing presence in interventional cardiology. Patient morbidity due to conditions where blood flow to tissues is impaired or otherwise compromised is one of the most significant healthcare segments ......more

Transfusions of whole blood and blood components represent one of the most widely used life-saving procedures in the healthcare sector. But the complexities of human blood along with the risks of transmitting blood borne diseases and the uncertainty of adequate factor-matched supplies has long been the Achilles heel of blood donations and blood product ......more